MBX Biosciences (MBX) Retained Earnings (2023 - 2026)

MBX Biosciences has disclosed Retained Earnings across 4 years of filings, most recently posting -$248.0 million for Q1 2026.

• Retained Earnings for Q1 2026 came in at -$248.0 million, down 468024.53% year-over-year; the trailing twelve-month figure through Mar 2026 was -$248.0 million (down 468024.53% YoY), and the FY2025 annual result was $286000.0, up 420.0% from the prior year.
• Retained Earnings came in at -$248.0 million for Q1 2026 at MBX Biosciences, down from $286000.0 in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $286000.0 in Q4 2025 to a low of -$248.0 million in Q1 2026.
• The 4-year median for Retained Earnings is -$98.8 million (2023), against an average of -$103.5 million.
• Across the five-year window, Retained Earnings soared 420.0% in 2025 and plunged 468024.53% in 2026, its largest moves.
• MBX Biosciences' Retained Earnings stood at -$75.6 million in 2023, then jumped by 100.07% to $55000.0 in 2024, then jumped by 420.0% to $286000.0 in 2025, then sank by 86813.29% to -$248.0 million in 2026.
• The last three Retained Earnings figures came in at -$248.0 million (Q1 2026), $286000.0 (Q4 2025), and -$202.4 million (Q3 2025), per Business Quant data.